Eosinophilic Esophagitis (EoE) Studies

Eosinophilic Esophagitis (EoE) research studies currently enrolling new participants

Clinical Trial: Oral Budesonide in Subjects with EoE

Meritage Pharma Inc

ENROLLMENT IS CURRENTLY CLOSED

Purpose: This Phase II study is comparing oral budesonide (OBS) to placebo to demonstrate that OBS improves dysphagia symptoms and induces a histologic response (in esophageal biopsies) over a 16 week course of therapy.
Participants: Patients with eosinophilic esophagitis (EoE) between 12 and 25 years old.
Procedures (methods):
Patients will undergo an upper endoscopy with esophageal biopsies, complete a daily diary regarding dsyphagia symptoms, and take the study drug daily.

Sponsor: Meritage Pharma, Inc

Principal Investigator: Dr. Evan Dellon
Research Coordinator:
Jessica Hores Gebhart
jhores@med.unc.edu 919-966-4591
ClinicalTrials.gov website:
OBS Study clinicaltrials.gov